Loss of heterozygosity in ductal carcinoma in situ of the breast.
about
The diagnosis and management of pre-invasive breast disease: genetic alterations in pre-invasive lesionsThe diagnosis and management of pre-invasive breast disease: promise of new technologies in understanding pre-invasive breast lesionsThe diagnosis and management of pre-invasive breast disease: another point of viewUnderstanding the premalignant potential of atypical hyperplasia through its natural history: a longitudinal cohort study.Ductal carcinoma in situ of the breast.Abnormal regulation of the oestrogen receptor in benign breast lesions.Independent predictors of breast malignancy in screen-detected microcalcifications: biopsy results in 2545 cases.Loss of heterozygosity and microsatellite instability in breast hyperplasia. No obligate correlation of these genetic alterations with subsequent malignancy.Molecular analysis of premalignant and carcinoma in situ lesions of the human breast.Estrogen receptor-positive proliferating cells in the normal and precancerous breast.Precancerous Lesions of the BreastIntraductal proliferative lesions of the breast-terminology and biology matter: premalignant lesions or preinvasive cancer?Allelic imbalance in the region of the BRCA1 gene in ductal carcinoma in situ of the breastMutation of the TP53 gene and allelic imbalance at chromosome 17p13 in ductal carcinoma in situ.Breast pathology practice: most common problems in a consultation service.Evaluating the efficacy of post-surgery adjuvant therapies used for ductal carcinoma in situ patients: a network meta-analysis.A critical evaluation of loss of heterozygosity detected in tumor tissues, blood serum and bone marrow plasma from patients with breast cancer.Mapping loss of heterozygosity in normal human breast cells from BRCA1/2 carriers.The molecular journey from ductal carcinoma in situ to invasive breast cancer.Breast ductal carcinoma in situ: morphologic and kinetic MRI findings.Amplification of the urokinase-type plasminogen activator receptor (uPAR) gene in ductal pancreatic carcinomas identifies a clinically high-risk group.Microdissection of stained archival tissueAtypical ductal hyperplasia of the breast: clonal proliferation with loss of heterozygosity on chromosomes 16q and 17p.The nuclear coactivator amplified in breast cancer 1 maintains tumor-initiating cells during development of ductal carcinoma in situGenome evolution in ductal carcinoma in situ: invasion of the clones.Presence of ductal carcinoma in situ confers an improved prognosis for patients with T1N0M0 invasive breast carcinoma.Prevalence of c-myc expression in breast lesions associated with microcalcifications detected by routine mammography.Application of the van nuys prognostic index in a retrospective series of 367 ductal carcinomas in situ of the breast examined by serial macroscopic sectioning: practical considerations.The theory of the sick breast lobe and the possible consequences.Gene amplifications detected by fluorescence in situ hybridization in pure intraductal breast carcinomas: relation to morphology, cell proliferation and expression of breast cancer-related genes.How to prevent invasive breast cancer: detect and excise duct carcinoma in situ.
P2860
Q24802857-B3540DB6-A5D5-4F85-B2B0-F13266EC52E0Q24803014-789BA046-2007-4B14-B134-1A0FBFFD0F0EQ24803959-F77EF6A1-0863-496D-86CC-4D00A9F9222AQ30408300-3EB7E1D0-F3F1-474D-8348-7DDE501BA39DQ33791890-54BDE0C0-E3CB-4E6E-BE8E-97AEFA669AE5Q35394758-25F87A0A-2BA3-4AD4-838B-E3B0308588D6Q35623350-66F02EAE-3783-41EC-BB79-6CF6DB191224Q35764821-A5A61679-3718-48C9-86AB-83A72CC06045Q35782037-7E40A5F9-B9DE-4185-A2AC-442D4706E182Q35787982-D775EBDD-9C8B-4F7E-B2FA-79C94680784BQ35940061-AF7E3F90-07F6-4D2B-97ED-38431BAC6E6AQ35979090-72617109-3182-44B4-90ED-6F2AE581E679Q36134576-C6DC0C5D-C105-4252-BF68-B8E3C0AA12ABQ36136580-6061FA63-3426-4314-A737-F3EA575DB7B1Q36293509-7FC4C575-8246-4444-9C22-09B38A151B99Q36370970-79ACC42E-BAB0-4FB0-8324-662677373DBEQ36458751-44E3A83A-8966-4C03-B9AC-B1053CEE8142Q36612219-EFC3746D-A0AB-4AD3-941A-9A151FDA7721Q37126345-451A2951-DDFE-4B6E-9991-EDF571836EEAQ37156041-B291C020-D211-4FBB-BADB-23A23D7DE971Q37197386-FB8B95C2-FE91-4868-88A9-646EDB76CA20Q37229066-A7AFC595-391B-44AC-B6E5-C6EE44A3BFE0Q37263268-BFD775A4-6198-4ECA-BDBA-84C2BF5A70ACQ37619321-088780DA-5DAD-4BB3-B08C-39BC0D85F4FFQ39012815-BBB5D190-B09A-42A4-BADA-262A28A1B598Q44107440-9407E30F-F22B-412A-A6E8-F1D1A0D1E871Q44156752-5E1E491D-8881-49F1-9ECE-B2FE29B904DBQ44584714-CA3EA38C-AA9D-402F-B730-CE0EB99B88B2Q53328453-EB8EF79F-ACDA-4070-A2E1-3789827F4AD2Q53405502-E234BE08-E2DA-4A5F-AE32-E547360A8BDAQ53680068-2FCCA9ED-B0E6-447C-89CC-2E4FFD13B080
P2860
Loss of heterozygosity in ductal carcinoma in situ of the breast.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh-hant
name
Loss of heterozygosity in ductal carcinoma in situ of the breast.
@en
Loss of heterozygosity in ductal carcinoma in situ of the breast.
@nl
type
label
Loss of heterozygosity in ductal carcinoma in situ of the breast.
@en
Loss of heterozygosity in ductal carcinoma in situ of the breast.
@nl
prefLabel
Loss of heterozygosity in ductal carcinoma in situ of the breast.
@en
Loss of heterozygosity in ductal carcinoma in situ of the breast.
@nl
P356
P1476
Loss of heterozygosity in ductal carcinoma in situ of the breast
@en
P2093
P304
P356
10.1002/PATH.1711750207
P577
1995-02-01T00:00:00Z